Toronto Dominion Bank Abcam PLC Transaction History

Toronto Dominion Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 14, 2024	SELL	$21.54 - $24.41 $11,093 - $12,571	-515 Reduced 27.03%	1,390 $31,000
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $11,093 - $12,571	-515 Reduced 27.03%	1,390 $31,000
Q2 2023 Feb 14, 2024	BUY	$12.62 - $24.47 $24,041 - $46,615	1,905 New	1,905 $47,000
Q2 2023 Aug 10, 2023	BUY	$12.62 - $24.47 $126 - $244	10 Added 0.53%	1,905 $47,000
Q2 2022 Aug 11, 2022	BUY	$12.69 - $19.25 $7,436 - $11,280	586 Added 44.77%	1,895 $27,000
Q1 2022 May 09, 2022	BUY	$15.5 - $23.89 $759 - $1,170	49 Added 3.89%	1,309 $24,000
Q4 2021 Feb 04, 2022	BUY	$20.04 - $23.84 $2,925 - $3,480	146 Added 13.11%	1,260 $30,000
Q3 2021 Nov 08, 2021	BUY	$17.38 - $21.54 $1,199 - $1,486	69 Added 6.6%	1,114 $23,000
Q2 2021 Aug 13, 2021	BUY	$18.47 - $22.11 $19,301 - $23,104	1,045 New	1,045 $20,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.